ImmuCell
ICCC
25 hedge funds and large institutions have $9M invested in ImmuCell in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 9 increasing their positions, 2 reducing their positions, and 3 closing their positions.
350% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 2
55% more capital invested
Capital invested by funds: $5.79M → $9M (+$3.21M)
1.06% more ownership
Funds ownership: 13.46% → 14.52% (+1.1%)
7% less funds holding
Funds holding: 27 → 25 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$485K |
| 2 |
Morgan Stanley
New York
|
+$163K |
| 3 |
Renaissance Technologies
New York
|
+$152K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$99.2K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$16.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DIG
Dauntless Investment Group
Etna,
New Hampshire
|
-$213K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$64.7K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$49.6K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.87K |
| 5 |
JP Morgan Chase
New York
|
-$48 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$64.7K | -13,501 | Closed |
|
|
TRCT
27
Tower Research Capital (TRC)
New York
| – | -$4.87K | -1,017 | Closed |
|
|
28
JP Morgan Chase
New York
| – | -$48 | -10 | Closed |
|
ICCC Hedge Fund Activity: Q2 2025 in Review
25 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q2 2025, worth a combined $9M — up 55% from $5.79M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of ICCC and 1 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 9 added.
The largest buyer was Vanguard Group, adding an estimated $485K. The largest seller was Dauntless Investment Group, cutting an estimated $213K.
- 25 institutional investors held ImmuCell (ICCC) as of Q2 2025, down from 27 in Q1 2025.
- Funds reported $9M of ImmuCell stock for Q2 2025, up 55% quarter-over-quarter.
- 1 fund opened new ImmuCell positions in Q2 2025 and 3 closed out, a net change of -2 holders.
- The largest ImmuCell buyer in Q2 2025 was Vanguard Group, an estimated $485K added.
- The largest ImmuCell seller in Q2 2025 was Dauntless Investment Group, an estimated $213K sold.
Based on aggregated 13F filings for Q2 2025.